Stock data
Standard BioTools Inc. (LAB)
Standard BioTools Inc. (LAB) reported revenue of US$85.33M and net income of -US$74.90M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$85.33M | US$42.54M | -US$110.25M | -US$74.90M | — |
| 2024 | US$91.01M | US$44.88M | -US$127.48M | -US$138.88M | — |
| 2023 | US$106.34M | US$50.45M | -US$76.60M | -US$74.66M | — |
| 2022 | US$97.95M | US$37.05M | -US$116.20M | -US$190.10M | — |
| 2021 | US$130.58M | — | -US$67.46M | -US$59.24M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$20.10M | -US$26.76M | — |
| 2026-03-31 | US$21.15M | US$127.07M | — |
| 2025-12-31 | US$23.80M | US$19.28M | — |
| 2025-09-30 | US$19.55M | -US$34.69M | — |
| 2025-06-30 | US$21.76M | -US$33.46M | — |
| 2025-03-31 | US$20.22M | -US$26.03M | — |
| 2024-12-31 | US$0.89M | -US$34.07M | — |
| 2024-09-30 | US$22.09M | -US$26.94M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.